Management of patient participation in a hepatocellular carcinoma clinical trial
Diana Hull Clinical research nurses, Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham
Michelle Chester Clinical research nurses, Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham
Hepatocellular carcinoma (HCC) is the major form of liver cancer. Although it was historically rare in the UK, HCC is on the increase. Patients are often asymptomatic when they present with HCC, and treatment options are limited. This article uses a case study to demonstrate the role of the research nurse as an integral part of a multidisciplinary team when managing a patient with a poor prognosis in a clinical trial. The patient in question has inoperable HCC and co-morbid conditions.
Cancer Nursing Practice.
7, 2, 35-39.
doi: 10.7748/cnp2008.03.7.2.35.c6464
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Alternatively, you can purchase access to this article for the next seven days.
Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
